Developing a new implant to heal joint cartilage damage
Official title: Synthetic Cartilage-Capped, Regenerative Osteochondral Plugs to Heal Osteochondral Defects
Funded at Texas Engineering Experiment Station · NIH-11003737 · Data updated 2026-11-12
This study is testing a new type of implant designed to help people with joint problems, like knee pain from osteochondral defects, by using a special cap that encourages healing and new bone growth, making it easier for patients to get back to their normal activities.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Texas Engineering Experiment Station NIH-funded |
| Lab location | 1 site (College Station, United States) |
| Project start | January 1, 2024 |
| Project end | December 31, 2028 |
| Funding year | 2025 |
| Award (this year) | $605,403 |
| NIH project number | 5R01AR082652-02 |
| Project ID | NIH-11003737 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals with osteochondral defects in their knees or other joints who are seeking treatment options.
✕Less likely to help
Patients with advanced osteoarthritis or those who have already undergone multiple joint surgeries may not benefit from this research.
What this research studies
This research focuses on creating a novel bioprosthetic implant called a cartilage-capped, regenerative osteochondral plug (CC-ROP) to treat osteochondral defects (OCDs) in joints like the knees. The CC-ROP combines a synthetic cartilage cap with a biodegradable base that encourages new bone growth, aiming to restore joint function and alleviate pain. The implant is designed to integrate with surrounding tissues and can be inserted using current surgical methods, making it a practical option for patients. The study will evaluate the effectiveness of this innovative approach compared to traditional treatments such as autografting and allografting.
Why it matters
Potential benefit: If successful, this research could provide a more effective treatment option for patients suffering from osteochondral defects, potentially reducing pain and improving joint function.
How similar studies have gone: While the approach of using synthetic materials for cartilage repair is being explored, this specific combination of a cartilage cap and biodegradable scaffold represents a novel strategy in the field.
Where this research is happening
-
Texas Engineering Experiment Station
College Station, United States Active
Researchers
- Principal investigator: Grunlan, Melissa — Texas Engineering Experiment Station
- Study coordinator: Grunlan, Melissa
Related research
Other NIH-funded projects on the same topics.
-
Robotic dental implants to deliver stem cells
A new wireless robotic implant approach aims to improve bone healing and implant stability by delivering stem cells directly at the implant site for people needing dental implants.
-
Digital Twin for Personalized Spine Fracture Prediction in Osteoporosis
A patient-focused project that uses CT scans and a digital twin model to predict where an osteoporotic spine might fracture during everyday activities.
-
Nanoparticle therapy to reduce alcohol-related liver scarring and cancer risk
This project is developing tiny particles that deliver anti-fibrotic medicine to livers damaged by heavy drinking to help reduce scarring and lower the chance of liver cancer.
-
Smart wrist wearable for continuous cuffless blood pressure and vital signs across diverse skin tones
A wearable wrist device will continuously monitor blood pressure, heart rate, and breathing in adults of diverse skin tones and body types, using non-invasive sensors and smart algorithms.
-
Role of the Nucleus in YAP/TAZ Control in Head and Neck Cancer
Aims to understand how changes in the cell nucleus influence YAP/TAZ pathways that drive head and neck cancer, with the hope of finding biomarkers for treatment response.
-
Targeted nanoparticle therapy for lung fibrosis
A researcher team is testing inhaled nanoparticles that deliver medicine directly to the lungs to slow or stop scarring in people with pulmonary fibrosis.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.